News & Analysis as of

Healthcare › Diversity and Inclusion Standards (D&I) › Diversity

Latham & Watkins LLP

Week 7 in Review: Rollbacks, Rescissions, and Reserves

Latham & Watkins LLP on

The administration continues to advance its agenda via executive orders amid confusion around rollbacks and rescissions. Last week, the Trump administration continued to sign several new executive orders imposing and...more

Health Care Compliance Association (HCCA)

‘Waking Up With Panic Attacks’: NIH 15% Plan Caps Tumultuous Weeks Under New Administration

Health Care Compliance Association (HCCA) on

If NIH succeeds in imposing an across-the-board indirect cost rate of 15%, rough estimates indicate the University of Michigan could lose $119 million a year. Emory University could be down $75 million. For the University of...more

DLA Piper

Trump Administration’s DEI Executive Order and the Impact on FDA’s DAP Draft Guidance: Top Points

DLA Piper on

For more than a decade, the Food and Drug Administration (FDA) has made diversity in clinical trials a focus, including by issuing guidance, convening public-private workshops, and completing data analyses in an effort to...more

Society of Corporate Compliance and Ethics...

DEI considerations for compliance professionals

Society of Corporate Compliance and Ethics... on

In recent years, diversity, equity, and inclusion (DEI) have gained heightened attention as organizations recognize the moral and business imperatives behind fostering diverse work environments. This shift is not only a...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide